E-health refers to health services and information supplied or enhanced via the Internet and similar technologies, and is a growing field at the crossroads of medical informatics, public health, and business. In a larger sense, the phrase describes not just a technological advancement, but also a state of mind, a style of thinking, an attitude, and a commitment to utilize information and communication technology to enhance health care locally, regionally, and globally. As a result, the "e" in e-health denotes not only "electronic," but also a slew of other "e's" that, taken together, may best describe what e-health is all about (or what it should be).
Telemedicine uses telecommunications technology to allow health care providers to evaluate, diagnose, and treat patients from a distance. In the recent decade, the method has undergone a significant transformation, and it is becoming an increasingly vital part of the American healthcare system. In the beginning, telemedicine was primarily utilized to connect doctors treating a patient in one area with specialists in another. This was especially beneficial to rural or hard-to-reach populations where specialists are few. The equipment required to conduct remote visits remained expensive and difficult for the next few decades, so the approach's application remained limited, even as it grew. The advent of the internet ushered in significant changes in the practice of telemedicine. With the emergence of smart devices capable of high-quality video transmission, remote healthcare can now be delivered to patients in their homes, workplaces, or assisted living facilities as an alternative to in-person visits for both primary and specialist care.
This is to inform that due to some circumstances beyond the organizer control, “Euro Global Conference on Proteomics, Genomics and Bioinformatics” (Proteomics 2023) during September 18-20, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at proteomics@magnusconference.com or call +1 (702) 988 2320.
Title : Development of proteomic biomarkers in pancreatic cancer
Ru Chen, Baylor College of Medicine, United States
Title : Nutrition and proteomics: The need for N-of-1 experimental strategies
Jim Kaput, Vydiant, United States
Title : Discovering novel catalytic variants of peroxygenases and antioxidant enzymes in metagenomes and proteomoes from primeval forests in Middle Europe
Marcel Zamocky, Laboratory for Phylogenomic Ecology, Institute of Molecular Biology, Slovak Academy of Sciences, Slovakia (Slovak Republic)
Title : Crispr/Cas9 In Gossypium Hirsutum (Cotton) Coker 312 For Clcud Cotton Leaf Curl Virus Disease Resistance Mediated By Agrobacterium
Tahira Shafique, Fatima Jinnah College of Science and Commerce, Pakistan
Title : Analysis of data on behavioral characteristics of crazy people towards life in Indonesia, the vision of Indonesia being golden in 2045
Arman S Sos M Si, universitas ichsan Gorontalo, Indonesia
Title : The role of Gamma H2AX in apoptosis
Emmy Rogakou, University of Athens, Greece